These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21136705)

  • 1. Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.
    Dos Santos A; Thiers V; Sar S; Derian N; Bensalem N; Yilmaz F; Bralet MP; Ducot B; Bréchot C; Demaugre F
    Proteomics Clin Appl; 2007 Jun; 1(6):545-54. PubMed ID: 21136705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser capture microdissection in comparative proteomic analysis of hepatocellular carcinoma.
    Wang HY
    Methods Cell Biol; 2007; 82():689-707. PubMed ID: 17586277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis of hepatocellular carcinoma by laser capture microdissection.
    Ai J; Tan Y; Ying W; Hong Y; Liu S; Wu M; Qian X; Wang H
    Proteomics; 2006 Jan; 6(2):538-46. PubMed ID: 16342242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser microdissection for gene expression study of hepatocellular carcinomas arising in cirrhotic and non-cirrhotic livers.
    Tretiakova M; Hart J
    Methods Mol Biol; 2011; 755():233-44. PubMed ID: 21761308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.
    Chava S; Lee C; Aydin Y; Chandra PK; Dash A; Chedid M; Thung SN; Moroz K; Wu T; Nayak NC; Dash S
    Oncotarget; 2017 Jun; 8(25):40019-40036. PubMed ID: 28402954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
    Blanc JF; Lalanne C; Plomion C; Schmitter JM; Bathany K; Gion JM; Bioulac-Sage P; Balabaud C; Bonneu M; Rosenbaum J
    Proteomics; 2005 Sep; 5(14):3778-89. PubMed ID: 16097030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte transformation is induced by laminin γ2 monomer.
    Funahashi N; Okada H; Kaneko R; Nio K; Yamashita T; Koshikawa N
    Cancer Sci; 2024 Jul; ():. PubMed ID: 38951133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development.
    Sobolewski C; Abegg D; Berthou F; Dolicka D; Calo N; Sempoux C; Fournier M; Maeder C; Ay AS; Clavien PA; Humar B; Dufour JF; Adibekian A; Foti M
    Gut; 2020 Oct; 69(10):1841-1854. PubMed ID: 31919231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
    Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
    BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.
    Chen XL; Zhou L; Yang J; Shen FK; Zhao SP; Wang YL
    Mol Med Rep; 2010; 3(4):589-96. PubMed ID: 21472284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
    Sobesky R; Feray C; Rimlinger F; Derian N; Dos Santos A; Roque-Afonso AM; Samuel D; Bréchot C; Thiers V
    Hepatology; 2007 Dec; 46(6):1704-12. PubMed ID: 17935229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.
    Reis H; Pütter C; Megger DA; Bracht T; Weber F; Hoffmann AC; Bertram S; Wohlschläger J; Hagemann S; Eisenacher M; Scherag A; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
    Biochim Biophys Acta; 2015 Jun; 1854(6):641-50. PubMed ID: 25448011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry.
    Li C; Hong Y; Tan YX; Zhou H; Ai JH; Li SJ; Zhang L; Xia QC; Wu JR; Wang HY; Zeng R
    Mol Cell Proteomics; 2004 Apr; 3(4):399-409. PubMed ID: 14726492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome analysis of hepatocellular carcinoma.
    Lim SO; Park SJ; Kim W; Park SG; Kim HJ; Kim YI; Sohn TS; Noh JH; Jung G
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1031-7. PubMed ID: 11866469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: from bedside to proteomics.
    Seow TK; Liang RC; Leow CK; Chung MC
    Proteomics; 2001 Oct; 1(10):1249-63. PubMed ID: 11721636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
    Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye.
    Fujii K; Kondo T; Yokoo H; Yamada T; Iwatsuki K; Hirohashi S
    Proteomics; 2005 Apr; 5(5):1411-22. PubMed ID: 15751005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
    Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial proteome profiling by immunohistochemistry-based laser capture microdissection and data-independent acquisition proteomics.
    Huang P; Kong Q; Gao W; Chu B; Li H; Mao Y; Cai Z; Xu R; Tian R
    Anal Chim Acta; 2020 Aug; 1127():140-148. PubMed ID: 32800117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.